Founded as recently as December 2013, Trianta Immunotherapies GmbH has already closed a successful agreement with Medigene AG: its acquisition by the listed company was announced on 27 January. This is a significant step for Medigene: it obtains three new platforms for the development of T-cell therapies against cancer, one of which is already in…
Ascenion and the Charité - Universitätsmedizin Berlin are working together to improve the transfer of scientific findings into applications.
Ascenion’s services for Charité cover all aspects of technology transfer, from the identification of commercially attractive research results and securing patent protection through to commercialization,…
Ascenion and the Universität zu Lübeck have initiated a collaboration as part of “EXIST Culture of Entrepreneurship”, a support programme of the German Federal Ministry of Economics and Energy (BMWi). Ascenion is advising the Universität zu Lübeck on how the various structures for entrepreneur support on the Lübeck Campus can be consolidated and…
Dr Julia Eschenbrenner joined our Berlin team as a Technology Scout in November, where together with her colleagues, she will be supporting Ascenion’s partners in the region, especially the Charité.
Before joining Ascenion, she worked as a scientist in the biopharmaceutical industry, initially at Cambridge Antibody Technology in Cambridge, UK,…
Berlin / Bonn, 13 December 2013 -- The human heart beats 60 to 100 times a minute – on average about 42 million times a year. Disturbances of the heart’s rhythm – so called arrhythmias – are not uncommon, especially in older people. Atrial fibrillation, the most frequently occurring arrhythmia, and typically presents with irregular palpitations,…
In our latest edition you can read about new start-ups from our partner institutes that aim to improve oncological surgery and the treatment of heart arrhythmias, discover what Professor Thomas Thum thinks about technology transfer, and learn about new features we are planning for BioVaria 2014. We have also put together ‘news in…
Christine Uplegger has been supporting the accounts department in our Munich headquarters since August. She has many years’ experience in this area, working in various sectors and regions. She completed her training in wholesale and foreign trade in Freiburg i. Br.
Dr Petra Köhler joined Ascenion as a Technology Manager in October. Based in our…
Ascenion’s portfolio company Vakzine Projekt Management GmbH (VPM) and Serum Institute of India (SII) have closed a license agreement providing the institute with the rights to develop and market VPM’s innovative vaccine for the prevention of tuberculosis. The candidate was jointly developed by VPM and scientists of the Max Planck Society and the…
3 July 2013, Munich and Karlsruhe -- Ascenion GmbH and the Karlsruhe Institute of Technology (KIT) will work together to further improve the transfer of the institute’s scientific findings into application. The partners will focus their collaboration on the life-sciences field.KIT is the 6th member of the Helmholtz Association to team up with…
The Association of Science and Technology Professionals (ASTP) and ProTon-Europe have decided to merge into one pan-European association for knowledge and technology transfer. Together, they aim to provide ‘the best possible combination of services to the European knowledge and technology transfer community’. Key issues will be professional…
15 May 2013, Munich -- Ascenion GmbH congratulates Prof. Klaus Brandenburg, scientist at the Research Center Borstel – Leibniz Center for Medicine and Biosciences (FZB), who was today announced winner of the Innovation Prize of the BioRegions in Germany 2013. Prof. Brandenburg’s work on sepsis addresses a condition of which there is little public…
In our new issue you can find out why Dr Jörn Erselius believes the label ‘RTTP’ to be useful, how many agreements and revenues Ascenion has achieved for its partners in 2012 and which projects have been funded by the LifeScience Foundation. You can also read our news in brief and information on forthcoming events.
Download ‚Ascenion…
Ascenion and the High-Tech Gründerfonds (HTGF) will work closely together to further improve the transfer of academic research into application. The partners agreed on shared principles and standards for developing entrepreneurial projects effectively and sustainably. Particularly the Spinnovator initiative has been identified as a suitable…
Only 4 weeks left until BioVaria 2013! Come and join us for this unique European showcasing event!
Check out the BioVaria 2013 Agenda: www.biovaria.org/agenda_2013
BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international biopharmaceutical…
Together with leading European technology transfer organizations, Ascenion will support the ENTENTE professional exchange program as a host company. Young technology transfer professionals working for universities, public research organizations or hospitals all over Europe will have the opportunity to join Ascenion’s team for six weeks and learn…
